Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA
In the study, there were improvements in motor function as well as a slowing of neurodegeneration
Read More
Jun 5, 2026 | News, Regulatory
In the study, there were improvements in motor function as well as a slowing of neurodegeneration
Read MoreThe deal will assist accelerate the discovery of RNAi therapeutics
Read MoreThe drug showed improvements in overall survival and progression-free survival in two cancers
Read MoreErleada plus hormone therapy significantly improved key short- and long-term clinical outcomes
Read MoreThe companies plan to research and develop 12 new cancer treatments
Read MoreJun 1, 2026 | News, Healthcare
The EU body underlines its commitment to diverse perspectives in medicines regulation
Read MoreOver 240 million people worldwide live with chronic hepatitis B
Read MoreMay 28, 2026 | News, Regulatory
It is estimated that 3,300 women are diagnosed with cervical cancer in the UK each year
Read MoreRoche and Alnylam share their experiences entering the PMEAs
Read MoreThe acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
Read MoreMay 26, 2026 | News, Regulatory
Hypertension affects more than 1.4 billion people worldwide and many patients remain uncontrolled despite multiple therapies
Read MoreThe acquisition will help build Lilly’s infectious disease portfolio
Read More
